Cleared Traditional

MouthLab Vital Signs Monitoring System (K201635) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2021
Decision
235d
Days
Class 2
Risk

K201635 is an FDA 510(k) clearance for the MouthLab Vital Signs Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Multisensor Diagnostics (Dba Aidar Health) (Pikesville, US). The FDA issued a Cleared decision on February 6, 2021 after a review of 235 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Multisensor Diagnostics (Dba Aidar Health) devices

Submission Details

510(k) Number K201635 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 16, 2020
Decision Date February 06, 2021
Days to Decision 235 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 125d · This submission: 235d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Acknowledge Regulatory Strategies, LLC
Allison C. Komiyama

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 114
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K201635.
Vitals360 Multi-Vitals Mobile Monitor
K210086 · Vocare, Inc. · May 2021
ZOLL Propaq M
K202375 · ZOLL Medical Corporation · Mar 2021
740 SafeSAT
K200160 · Zoe Medical, Inc. · Feb 2021
Vital Signs Monitor:iM3s, iM3As, iM3Bs, iHM3s
K202892 · Edan Instruments, Inc. · Jan 2021
T3 Platform software
K202306 · Etiometry, Inc. · Nov 2020
Masimo Rad-97 Pulse CO-Oximeter and Accessories
K193626 · Masimo Corporation · Aug 2020